A Digital Bridge To Real-Time COVID-19 Data
Several years ago, the Digital Bridge collaborative was formed, consisting of representatives from three key stakeholder communities: public health, the health care [...]
Former FDA Commish Califf: Weighing the Benefits & Risks of the Growing Number of Observational Treatment Assessments
In a recently published JAMA Viewpoint, former FDA Commissioner Robert Califf and colleagues mused about a growing concern about inferring [...]
Sneak Peak at Pharma Industry Survey on Observational Research: Progress not Perfection
By Jeff Trotter, President, Continuum Clinical I write this blog the evening before giving a presentation on observational research to [...]
Advertisement
